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Background 
It is suspected that the prevalence of Neuropathic pain (NeP) is higher in the countries normally 
categorized as belonging to the global South, i.e. developing countries, because of the high 
prevalence of NeP generating diseases including HIV, diabetes mellitus and cancer. However, few 
articles have estimated the prevalence of NeP in these limited resource countries. By contrast, the 
prevalence of NeP worldwide has been evaluated in two systematic reviews to range between 3.3% 
in Austria to 8.2% in the UK (Smith and Torrance, 2012, Hecke et al., 2014) with an outlier of 
prevalence at 17% in Canada. 
Aims 
The aim of this systematic review was to screen the literature for the prevalence of NeP in the 
general population of the global South and to compare this prevalence with the prevalence in the 
global North using a meta-analytic approach. 
Methods 
Pubmed; Siencedirect; EMBASE; AMED and PsycINFO databases were searched on July 2016 to 
capture peer reviewed articles that contain data on NeP prevalence either in adult general 
populations or among chronic pain patients. Two reviewers applied the inclusion criteria and 
extracted information from all eligible studies including study period, country, study design, sample 
size, tools to diagnose NeP, outcome and overall prevalence and judged the outcome for each study 
by scrutinising the methods and result section. Guidelines for reporting Meta-Analysis of 
Observational Studies in Epidemiology (MOOSE) (Stroup, 2000) and Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) (Moher, 2009) were followed. Random effects 
modelling was applied on extracted data to produce the overall prevalence in the two study areas. 
Effect size and confidence intervals of overall prevalences was calculated by producing Forest plots 
in the Comprehensive Meta-analysis software. Risk of publication bias and heterogeneity between 
studies were also estimated. 
Results 
Out of the 624 studies identified in the search 14 studies were finally selected (total sample size of 
78421 patients, 8137 from developing countries (global south) and 70284 from developed countries 
(global north). The average quality score of all studies was 6.7 out of a maximum of 8. There was a 
high level of heterogeneity between the studies (I2>90) possibly because of differences in the target 
populations, sample sizes, study design and data collection methods. However, there was no 
publication bias as the Egger’s test value was not significant (p=0.053). The prevalence of NeP 
worldwide was 4.8 % (95%CI, 4.7%-5.0%). Only four studies were conducted in the global South; 2 in 
Libya, 1 in Morocco and 1 in Brazil. The prevalence of NeP in the global South was 8.3% (7.7%-9.0%). 
The overall prevalence in the global North was 4.9% (4.7%-6.0%). 
Conclusion 
There were few studies on the prevalence of NeP in the global South suggesting that there is less 
awareness of the significance of NeP in the developing countries. Differences exist between the 
studies in each region in the estimate of the prevalence of NeP and this is mainly because of 
differences in data collection methods. Clinical examination tends to produce more variable 
estimates than telephone, postal and internet based questionnaires using NeP screening tools such 
as DN4 and S-LANSS. This meta-analysis tentatively suggests that the prevalence of NeP is 
significantly higher in the global South compared to global North. 
